Thursday, May 5th, 2016

According to researcher, the Global Next Generation Cancer Diagnostics market is estimated at $2.95 billion in 2015 and is expected to grow at a CAGR of 32.6% to reach $20.93 billion by 2022. Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global next generation cancer diagnostics market growth over the forecast period. 

Complete report details @

The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region. 

Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-a-chip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot. 

Cancer Type Covered: 
• Lung Cancer 
• Colorectal Cancer 
• Cervical Cancer 
• Breast Cancer 
• Other Cancer Types 


Request a sample report @

Functions Covered: 
• Therapeutic Monitoring 
• Risk analysis 
• Prognostics diagnosis 
• Companion Diagnostics 
• Cancer Screening 
Technologies Covered: 
• Platform-Based Diagnostics 
o Polymerase Chain Reaction (PCR) 
o Next-Generation Sequencing (NGS) 
o Microarrays 
o In Situ Hybridization (ISH) 
o Immunohistochemistry (IHC) 
o Flow Cytometry 
o Other Technologies 
• Instrument-Based 
o Diagnostic Imaging 
o Ultrasound 
o Mammography 
• Biopsies 

What our report offers: 
- Market share assessments for the regional and country level segments 
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants 
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic recommendations in key business segments based on the market estimations 
- Competitive landscaping mapping the key common trends 
- Company profiling with detailed strategies, financials, and recent developments 
- Supply chain trends mapping the latest technological advancements


Make an enquiry before buying this Report @


Table of content

1 Executive Summary 
2 Preface 
2.1 Abstract 
2.2 Stake Holders 
2.3 Research Scope 
2.4 Research Methodology 
2.4.1 Data Mining 
2.4.2 Data Analysis 
2.4.3 Data Validation 
2.4.4 Research Approach 
2.5 Research Sources 
2.5.1 Primary Research Sources 
2.5.2 Secondary Research Sources 
2.5.3 Assumptions 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 
3.6 Application Analysis 
3.7 Technology Analysis 
3.8 Emerging markets 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

5 Global Next Generation Cancer Diagnostics Market, By Application 
5.1 Introduction 
5.2 Proteomic Analysis 
5.3 Epigenetic Analysis 
5.4 Genetic Analysis 
5.5 Biomarker Development 
5.6 CTC Analysis 

6 Global Next Generation Cancer Diagnostics Market, By Technology 
6.1 Introduction 
6.2 Lab-on-a-chip 
6.3 DNA Microarrays 
6.4 Multiplexed assays 
6.5 RT-PCR & Multiplexing 
6.6 Protein Microarrays 
6.7 Cellular capture and identification 
6.8 Next Generation Sequencing 
6.9 Benchtop Sequencers 
6.10 Other Technologies 

7 Global Next Generation Cancer Diagnostics Market, By Function 
7.1 Introduction 
7.2 Prognosis Diagnostics 
7.3 Companion Diagnostics 
7.4 Cancer Screening 
7.5 Risk Analysis 
7.6 Therapeutic Monitoring 

8 Global Next Generation Cancer Diagnostics Market, By Cancer Type 
8.1 Introduction 
8.2 Sex-related tumors 
8.2.1 Cervical Cancer 
8.2.2 Breast Cancer 
8.2.3 Ovarian Cancer 
8.2.4 Prostate Cancer 
8.3 Blood-born cancers 
8.3.1 Myeloma 
8.3.2 Leukemia 
8.3.3 Lymphoma 
8.4 Lung Cancer 
8.5 Solid tumors 
8.6 Colorectal Cancer 
8.7 Other Cancers 

9 Global Next Generation Cancer Diagnostics Market, By Geography 
9.1 North America 
9.1.1 US 
9.1.2 Canada 
9.1.3 Mexico 
9.2 Europe 
9.2.1 Germany 
9.2.2 France 
9.2.3 Italy 
9.2.4 UK 
9.2.5 Spain 
9.2.6 Rest of Europe 
9.3 Asia Pacific 
9.3.1 Japan 
9.3.2 China 
9.3.3 India 
9.3.4 Australia 
9.3.5 New Zealand 
9.3.6 Rest of Asia Pacific 
9.4 Rest of the World 
9.4.1 Middle East 
9.4.2 Brazil 
9.4.3 Argentina 
9.4.4 South Africa 
9.4.5 Egypt 

10 Key Developments 
10.1 Agreements, Partnerships, Collaborations and Joint Ventures 
10.2 Acquisitions & Mergers 
10.3 New Product Launch 
10.4 Expansions 
10.5 Other Key Strategies 

11 Company Profiling 
11.1 Abbott Laboratories 
11.2 Agilent Technologies Inc 
11.3 GE Healthcare 
11.4 Genomic Health Inc. 
11.5 Hologic Inc. 
11.6 Illumina Inc. 
11.7 Johnson & Johnson 
11.8 Myriad Genetics Inc. 
11.9 Novartis AG 
11.10 Opko Health Inc. 
11.11 Perkin Elmer Inc. 
11.12 Philips Electronics NV 
11.13 Qiagen 
11.14 Roche Holding AG 
11.15 Thermo Fisher Scientific Inc. 

Buy this report @


Contact US:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)



File Library

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Next generation cancer diagnostics market trend, Next generation cancer diagnostics market segmentation, Next generation cancer diagnostics market analysis, Next generation cancer diagnostics market parameters, Next generation cancer diagnostics indu




More Formats

View QR Code